Fractyl Health, Inc. (Nasdaq: GUTS) announced the appointment of Lara Smith Weber as Chief Financial Officer.
Ms. Smith Weber brings over 20 years of financial leadership experience in medtech, biotech, and growth-oriented industries.
She will oversee finance, accounting, and investor relations, supporting Fractyl's commercial-stage operations.
Experience in Growth-Stage Healthcare Companies
Lara Smith Weber has a strong track record in building disciplined financial organizations for commercial-stage operations.
Strategic Financial Expertise
She will partner with the executive team and Board of Directors to guide Fractyl through scale with regulatory and market complexities.
Transition from Chronic Management to Remission
Fractyl aims to move beyond chronic care to durable disease-modifying therapies for metabolic diseases like obesity and type 2 diabetes.
- The appointment of Lara Smith Weber signals Fractyl's focus on financial discipline and commercial readiness.
- Her experience aligns with the Company's goals to redefine metabolic disease treatment with durable solutions targeting root causes of obesity and type 2 diabetes.
Fractyl Health's strategic appointment of Lara Smith Weber demonstrates a commitment to financial strength and operational scale for its pioneering metabolic disease treatments.